Mass Tort

Attorneys handling a mass tort claim face compounding challenges: hundreds or thousands of plaintiffs spread across multiple jurisdictions, mountains of medical records, duplicative discovery demands, and the pressure to secure maximum settlement value for each client. The MDL role in mass tort claim litigation exists precisely to address these complexities. Multidistrict Litigation (MDL) is the […]

If your law firm is evaluating remdesivir lawsuits whether involving wrongful death, kidney failure, or lack of informed consent the outcome of your case will likely hinge on the strength of your expert medical testimony. Remdesivir (brand name Veklury), the antiviral drug manufactured by Gilead Sciences, was administered widely to hospitalized COVID-19 patients under Emergency

Attorneys and law firms handling proton pump inhibitor (PPI) litigation are closely monitoring the PPI settlement payout date as multidistrict litigation continues to evolve. While claimants often focus on when they will be paid, legal teams must understand how settlement timelines work, what affects payout schedules, and how different defendants are progressing procedurally. This article

BREAKING: Fabuloso Lawsuit Updates 2026 Update: The original Fabuloso class action settlement ($1.93 million) received final court approval on April 25, 2024. The claim filing deadline has passed. The current focus is EPA enforcement against illegally imported Fabuloso products. Handling a Fabuloso mass tort case? See how our Medical Record Review supports your claim Fabuloso,

In today’s multifaceted litigation landscape, attorneys and law firms must develop effective Mass Tort Strategies if they wish to achieve the best results for their clients and build an enduring practice. Whether they are handling pharmaceutical-device claims, environmental toxic torts, or personnel liability class action alternatives, your firm’s approach to large scale claims can make

Nexium lawsuits regarding proton pump inhibitors (PPIs) continue to shape a significant corner of pharmaceutical mass tort litigation. As of October 2025, more than 11,000 PPI-related lawsuits remain active in federal court – separate from the roughly 11,000 claims AstraZeneca resolved in an earlier October 2023 settlement. This guide now includes the latest Nexium lawsuits

The Morphe lawsuit has received considerable attention among various sectors of the legal industry and the cosmetics industry. An investigation of Morphe Cosmetics, one of the top cosmetic brands in the field, has raised significant issues of product safety, legality and ethical conduct of business. For attorneys faced with cosmetic product liability claims, it is

Mass tort litigation presents attorneys with a unique and persistent challenge: managing large volumes of complex medical records across hundreds or even thousands of plaintiffs. Each claimant may have medical histories spanning multiple providers, years of treatment, and overlapping conditions that must be evaluated for relevance, causation, and damages. Without a clear, structured approach to

Tort law covers a wide range of case types attorneys handle, from routine negligence claims to complex mass tort litigation. What connects nearly all of them is the same underlying requirement: a clear, well-documented medical record establishing what happened, what harm resulted, and how directly the two are connected. This guide breaks down the main

Mass Tort Law is crucial in establishing how lawsuits involving pharmaceutical and medical devices are litigated in the United States. Since a single defective medication or a single faulty medical device could injure thousands of patients at the same time. Courts apply this legal methodology in order to handle complicated claims in a timely manner.